ATE512229T1 - Neuer vektor und expressionszelllinie zur massenproduktion von rekombinantem protein sowie verfahren zur produktion von rekombinantem protein damit - Google Patents

Neuer vektor und expressionszelllinie zur massenproduktion von rekombinantem protein sowie verfahren zur produktion von rekombinantem protein damit

Info

Publication number
ATE512229T1
ATE512229T1 AT07833373T AT07833373T ATE512229T1 AT E512229 T1 ATE512229 T1 AT E512229T1 AT 07833373 T AT07833373 T AT 07833373T AT 07833373 T AT07833373 T AT 07833373T AT E512229 T1 ATE512229 T1 AT E512229T1
Authority
AT
Austria
Prior art keywords
recombinant protein
cell line
production
new vector
expression cell
Prior art date
Application number
AT07833373T
Other languages
German (de)
English (en)
Inventor
In Young Choi
Chang Hwan Kim
Hyun Ji Lee
Seong Hee Park
Se Chang Kwon
Gwan Sun Lee
Original Assignee
Hanmi Holdings Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hanmi Holdings Co Ltd filed Critical Hanmi Holdings Co Ltd
Application granted granted Critical
Publication of ATE512229T1 publication Critical patent/ATE512229T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0026—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on CH-NH groups of donors (1.5)
    • C12N9/0028—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on CH-NH groups of donors (1.5) with NAD or NADP as acceptor (1.5.1)
    • C12N9/003—Dihydrofolate reductase [DHFR] (1.5.1.3)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
AT07833373T 2006-10-16 2007-10-16 Neuer vektor und expressionszelllinie zur massenproduktion von rekombinantem protein sowie verfahren zur produktion von rekombinantem protein damit ATE512229T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020060100507A KR100880509B1 (ko) 2006-10-16 2006-10-16 재조합 단백질의 대량 생산을 위한 신규한 벡터, 발현세포주 및 이를 이용한 재조합 단백질의 생산 방법
PCT/KR2007/005064 WO2008048037A1 (en) 2006-10-16 2007-10-16 A novel vector and expression cell line for mass production of recombinant protein and a process of producing recombinant protein using same

Publications (1)

Publication Number Publication Date
ATE512229T1 true ATE512229T1 (de) 2011-06-15

Family

ID=39314214

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07833373T ATE512229T1 (de) 2006-10-16 2007-10-16 Neuer vektor und expressionszelllinie zur massenproduktion von rekombinantem protein sowie verfahren zur produktion von rekombinantem protein damit

Country Status (8)

Country Link
US (1) US8957196B2 (enExample)
EP (1) EP2087118B1 (enExample)
JP (1) JP5076084B2 (enExample)
KR (1) KR100880509B1 (enExample)
CN (1) CN101605899B (enExample)
AT (1) ATE512229T1 (enExample)
ES (1) ES2366061T3 (enExample)
WO (1) WO2008048037A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101030978B1 (ko) * 2008-07-10 2011-04-28 (주) 에이프로젠 동물세포용 재조합 발현벡터
KR101681513B1 (ko) * 2010-02-04 2016-12-02 한미사이언스 주식회사 인간 난포자극 호르몬의 대량 생산 방법
TWI541252B (zh) 2010-10-26 2016-07-11 韓美科學股份有限公司 因子ｖｉｉ／ｖｉｉａ之量產方法
SI2721062T1 (sl) 2011-06-17 2019-03-29 Hanmi Science Co., Ltd. Konjugat, obsegajoč oksintomodulinski in imunoglobinski fragment, in uporaba le-tega
CA2851223A1 (en) 2011-10-06 2013-04-11 Hanmi Science Co., Ltd. Blood coagulation factor vii and viia derivatives, conjugates and complexes comprising the same, and use thereof
US9499584B2 (en) 2012-01-31 2016-11-22 Canvax Biotech S.L GPCR with improved cell surface expression
TWI641382B (zh) 2013-01-31 2018-11-21 韓美藥品股份有限公司 於包含因子ｖｉｉ之組成物中使病毒失活之方法
KR20150026024A (ko) * 2013-08-30 2015-03-11 한미약품 주식회사 인간 혈액응고 7인자 유도체의 대량 생산 방법
BR112016007547A2 (pt) * 2013-10-07 2018-01-23 Prestige Biopharma Pte. Ltd. ?vetor de expressão bicistrônico para expressão de anticorpos e método para a produção de anticorpos usando o mesmo?
RU2548806C1 (ru) * 2014-01-20 2015-04-20 Общество с ограниченной ответственностью "РД-БИОТЕХ" Синтетическая днк, кодирующая эритропоэтин человека, содержащий её вектор, способ получения штамма-продуцента эритропоэтина, штамм-продуцент эритропоэтина
KR20160113268A (ko) 2014-01-28 2016-09-28 베이징 한미 파마슈티컬 컴퍼니 리미티드 이기능 융합단백질,이의 제조방법 및 용도
KR102418477B1 (ko) 2014-12-30 2022-07-08 한미약품 주식회사 글루카곤 유도체
CN106496302B (zh) * 2015-09-08 2021-12-10 三生国健药业（上海）股份有限公司 一种用离子交换层析纯化蛋白质的方法
CN108753819B (zh) * 2018-05-31 2022-05-20 暨南大学 真核表达载体、真核表达系统、二者的制备方法和应用及gdf11蛋白
EP4276466A4 (en) 2021-01-08 2024-12-18 Beijing Hanmi Pharmaceutical Co., Ltd. ANTIBODY SPECIFICALLY BINDING WITH PD-L1 AND ANTIGEN-BINDING FRAGMENT OF ANTIBODY
EP4276111A4 (en) 2021-01-08 2025-04-30 Beijing Hanmi Pharmaceutical Co., Ltd. Antibody specifically binding to 4-1bb and antigen-binding fragment of antibody
EP4276115A4 (en) 2021-01-08 2024-12-18 Beijing Hanmi Pharmaceutical Co., Ltd. BISPECIFIC ANTIBODY IN HETERODIMERIC FORM SIMILAR TO A NATURAL ANTI-PD-1/ANTI-CD47 ANTIBODY STRUCTURE AND PRODUCTION THEREOF

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4399216A (en) 1980-02-25 1983-08-16 The Trustees Of Columbia University Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
KR0162021B1 (ko) * 1995-07-27 1998-11-16 김은영 에리트로포이에틴의 제조방법
KR100232640B1 (ko) * 1997-06-03 1999-12-01 박호군 에리트로포이에틴 (epo)을 생산하는 세포주, 그의 제조방법 및 이를 이용한 epo의 제조방법
PT986644E (pt) * 1997-07-23 2007-01-31 Roche Diagnostics Gmbh Preparação de eritropoietina por activação genética endógena com promotores virais

Also Published As

Publication number Publication date
CN101605899B (zh) 2013-07-31
US20100120089A1 (en) 2010-05-13
EP2087118B1 (en) 2011-06-08
CN101605899A (zh) 2009-12-16
WO2008048037A1 (en) 2008-04-24
EP2087118A4 (en) 2010-03-03
ES2366061T3 (es) 2011-10-14
JP5076084B2 (ja) 2012-11-21
US8957196B2 (en) 2015-02-17
EP2087118A1 (en) 2009-08-12
HK1137481A1 (en) 2010-07-30
JP2010506586A (ja) 2010-03-04
KR100880509B1 (ko) 2009-01-28
KR20080034364A (ko) 2008-04-21

Similar Documents

Publication Publication Date Title
ATE512229T1 (de) Neuer vektor und expressionszelllinie zur massenproduktion von rekombinantem protein sowie verfahren zur produktion von rekombinantem protein damit
MX2007002382A (es) Producci??n de anticuerpos anti-amiloides beta.
MX2007002380A (es) Produccion de polipeptidos.
DK1664318T3 (da) L-aminosyre-producerende mikroorganisme og fremgangsmåde til fremstilling af L-aminosyre
MX2007003906A (es) Metodos y composiciones para mejorar la produccion de proteinas recombinantes.
TW200619388A (en) Production of TNFR-lg
DE60331321D1 (de) Verfahren zur wirksamen rna-interferenz in säugerzellen
DK1208205T3 (da) Fremgangsmåder til frembringelse af L-aminosyrer ved hjælp af en forögelse af cellulært NADPH
EA200801074A1 (ru) Способы получения искусственных гибридных семян
NO20082783L (no) Induserbare ekspresjonssystemer
MX2009007246A (es) Plantas con rasgos relacionados con el rendimiento mejorado y un metodo para producirlas.
EA201001881A1 (ru) Пролинспецифичная протеаза из penicillium chrysogenum
EA201070229A1 (ru) Нуклеотидные последовательности msca1, влияющие на мужскую фертильность растений, и способ их применения
DK1573058T3 (da) Fremgangsmåde til forbedring af proteinproduktion
TW200638944A (en) Recombinant enterovirus 71 neutralizing antibodies and use thereof
ATE446374T1 (de) Verfahren zur enantioselektiven enzymatischen reduktion von ketoverbindungen
GB2439039A (en) Identification of a sterol acyltransferase gene
MX2010004699A (es) Plantas que tienen rasgos incrementados relacionados con el rendimiento y un metodo para producirlas.
TW200602487A (en) Polypeptides having DNA polymerase activity
ATE553194T1 (de) Verfahren zur dipeptidherstellung
EA200800098A1 (ru) Экспрессионный вектор и способ продуцирования высоких уровней белков
UA86781C2 (ru) Промотор для эпидермис-специфической трансгенной экспрессии в растениях
ATE451457T1 (de) Verfahren zur dipeptidherstellung
DK1639119T3 (da) Fremgangsmåde til mikrobiologisk isomerisering af alpha-hydroxycarboxylsyrer
ATE417938T1 (de) Neuartiges nukleotidgemisch für ein verbessertes nukleinsäureamplifikationsverfahren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties